Measurement of antipyrine half-life from urinary drug concentrations.
作者信息
Taylor G, Blaschke T F
出版信息
Br J Clin Pharmacol. 1984 Oct;18(4):650-2. doi: 10.1111/j.1365-2125.1984.tb02524.x.
Abstract
摘要
相似文献
1
Measurement of antipyrine half-life from urinary drug concentrations.通过尿药浓度测定安替比林半衰期。
Br J Clin Pharmacol. 1984 Oct;18(4):650-2. doi: 10.1111/j.1365-2125.1984.tb02524.x.
2
Serial measurements of plasma half-lives and urinary excretion of antipyrine in low-birth-weight infants.低体重儿血浆中安替比林半衰期及尿排泄的系列测定
Biol Neonate. 1975;27(5-6):289-301. doi: 10.1159/000240786.
3
The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.维拉帕米对人体中安替比林药代动力学及代谢的影响。
Br J Clin Pharmacol. 1986 Jun;21(6):655-9. doi: 10.1111/j.1365-2125.1986.tb05230.x.
4
Immediate decrease by hydrocortisone of the plasma half-life of antipyrine.氢化可的松使安替比林的血浆半衰期立即缩短。
Br J Pharmacol. 1973 Feb;47(2):434-6. doi: 10.1111/j.1476-5381.1973.tb08344.x.
5
Antipyrine metabolism in coke oven workers.焦炉工人的安替比林代谢情况
Arch Toxicol Suppl. 1991;14:201-4. doi: 10.1007/978-3-642-74936-0_41.
6
Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.人体中安替比林不同代谢途径的研究。I. 对健康志愿者口服250、500和1000毫克安替比林。
Br J Clin Pharmacol. 1979 Dec;8(6):529-37. doi: 10.1111/j.1365-2125.1979.tb01040.x.
7
Antipyrine metabolism in man.人体内安替比林的代谢
Life Sci. 1978 Dec 18;23(25):2485-90. doi: 10.1016/0024-3205(78)90172-8.
8
Antipyrine elimination in critically ill patients.
Intensive Care Med. 1979 May;5(2):69-71. doi: 10.1007/BF01686049.
9
Assessment of antipyrine kinetics by measurement in saliva.通过唾液测量评估安替比林动力学。
Br J Clin Pharmacol. 1976 Apr;3(2):321-5. doi: 10.1111/j.1365-2125.1976.tb00610.x.
10
Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.利福平治疗对猪体内己巴比妥和安替比林代谢的诱导作用。
Drug Metab Dispos. 1981 Nov-Dec;9(6):541-4.
引用本文的文献
1
Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance.用于预测被动肾小管重吸收和肾排泄清除率的新型最小生理模型。
Eur J Pharm Sci. 2016 Oct 30;94:59-71. doi: 10.1016/j.ejps.2016.03.018. Epub 2016 Mar 28.
2
Effect of acute and chronic exercise on hepatic drug metabolism.急性和慢性运动对肝脏药物代谢的影响。
Clin Pharmacokinet. 1985 Sep-Oct;10(5):426-31. doi: 10.2165/00003088-198510050-00004.
3
Ethical considerations in the conduct of clinical pharmacokinetic studies.临床药代动力学研究实施中的伦理考量
Clin Pharmacokinet. 1989 Oct;17(4):217-22. doi: 10.2165/00003088-198917040-00001.
4
Plasma antipyrine half-life can be determined from urine data.血浆安替比林半衰期可根据尿液数据来确定。
Br J Clin Pharmacol. 1987 Jun;23(6):715-9. doi: 10.1111/j.1365-2125.1987.tb03106.x.
本文引用的文献
1
Differential induction of antipyrine metabolism by rifampicin.利福平对安替比林代谢的差异诱导作用。
Eur J Clin Pharmacol. 1981;21(2):155-60. doi: 10.1007/BF00637517.
2
Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.安替比林代谢与司巴丁和异喹胍多态性氧化的关系。
Br J Clin Pharmacol. 1983 Mar;15(3):317-21. doi: 10.1111/j.1365-2125.1983.tb01505.x.
3
Drug urinary excretion data--some aspects concerning the interpretation.药物尿液排泄数据——关于解读的一些方面。
Br J Pharmacol Chemother. 1967 Feb;29(2):181-93. doi: 10.1111/j.1476-5381.1967.tb01951.x.
4
Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.利用血浆、唾液和尿液对安替比林、氨基比林和非那西丁进行的处置研究。
Clin Pharmacol Ther. 1975 Sep;18(3):259-72. doi: 10.1002/cpt1975183259.
5
Elimination of antipyrine from saliva as a measure of metabolism in man.通过测定唾液中安替比林的消除情况来衡量人体新陈代谢。
Clin Pharmacol Ther. 1975 Sep;18(3):249-58. doi: 10.1002/cpt1975183249.
6
Assessment of antipyrine kinetics by measurement in saliva.通过唾液测量评估安替比林动力学。
Br J Clin Pharmacol. 1976 Apr;3(2):321-5. doi: 10.1111/j.1365-2125.1976.tb00610.x.
7
Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.人体中安替比林不同代谢途径的研究。I. 对健康志愿者口服250、500和1000毫克安替比林。
Br J Clin Pharmacol. 1979 Dec;8(6):529-37. doi: 10.1111/j.1365-2125.1979.tb01040.x.
8
Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man.
Pharmacology. 1979;18(4):210-23. doi: 10.1159/000137254.
Zotero 插件